News | November 14, 2006

FDA Clears North American Scientific’s ClearPath HDR Breast Brachytherapy System

North American Scientific Inc., a leading manufacturer of brachytherapy sources, announced that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the high-dose rate radiation treatment design of ClearPath, its breast brachytherapy product designed to enhance current accelerated partial breast irradiation (APBI) treatment options.
"We believe that ClearPath's unique design will offer a new treatment alternative to women electing APBI as part of their Breast Conserving Therapy (BCT). The company's unique multichannel catheter system, which is inserted through a single incision, is designed to allow for either low-dose therapy, using the company's existing Prospera I-125 seeds, or high-dose rate treatments. Both of the ClearPath systems are designed to offer physicians greater flexibility in treatment planning and dose optimization to the target region while minimizing exposure to nearby healthy tissue," said L. Michael Cutrer, president & CEO of North American Scientific.
The ClearPath design really offers the best of both worlds when it comes to APBI treatment," said Dr. Rakesh Patel, professor of Radiation Oncology at the University of Wisconsin, who presented on the ClearPath device at ASTRO earlier this month along with Dr. David Schreiber of Littleton Radiation Oncology Center. "We have enjoyed collaborating with the team at North American Scientific and I look forward to treating patients with ClearPath since it offers an attractive alternative for physicians and patients seeking flexibility in breast cancer treatment," said Dr. Patel

Related Content

Oregon Tech Partners with Mindray for High-Tech Ultrasound Education
News | Ultrasound Imaging | August 04, 2017
To better prepare its ultrasound students to compete and thrive in the evolving healthcare environment, Oregon...
Carestream Shows Touch Prime Systems at Society for Vascular Ultrasound Conference
News | Ultrasound Imaging | August 03, 2017
Carestream will showcase its Carestream Touch Prime and Touch Prime XE Ultrasound Systems at the Society for Vascular...
Contrast Media from Bayer, trends in contrast media and developments in contrast media
Feature | Contrast Media | July 28, 2017 | By Dave Fornell
Here are several updates in medical imaging ...
3-D Vascular Ultrasound Quantifies Plaque Burden to Estimate Cardiovascular Risk
News | Cardiovascular Ultrasound | July 20, 2017
In a large, first-of-its-kind population, researchers found an experimental technique known as three-dimensional...
Floyd Medical Center Acquires Quartet of Toshiba Cardiac Ultrasound Systems
News | Cardiovascular Ultrasound | July 19, 2017
Floyd Medical Center in Rome, Ga., recently installed three new Aplio 500 Platinum CV ultrasound systems from Toshiba...
News | Ultrasound Imaging | May 15, 2017
Soundwaves LLC recently announced the diversification of its portable ultrasound services beyond obstetrics and...
Strain Imaging Improves Cardiac Surveillance of Certain Breast Cancer Patients
News | Cardio-oncology | May 03, 2017
Epsilon Imaging Inc. announced a research study using EchoInsight was presented at the American College of Cardiology (...
Cardiovascular Institute of the South Upgrades Cardiac Ultrasound With New Toshiba Medical Systems
News | Cardiovascular Ultrasound | April 17, 2017
April 17, 2017 — To bolster its technology and treatment capabilities for coronary and peripheral artery diseases acr
ASE, EACVI, focused update document, aortic stenosis, AS, echocardiography, new classification scheme
News | Cardiovascular Ultrasound | April 03, 2017
The American Society of Echocardiography (ASE) and the European Association of Cardiovascular Imaging (EASCVI) have...
Toshiba Medical, Aplio i900 cardiovascular ultrasound, FDA clearance, ACC 2017, RSNA 2017
Technology | Cardiovascular Ultrasound | March 20, 2017
March 20, 2017 — Cardiologists can now access the advanced...
Overlay Init